Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program

Chest

Volumn 142, Issue 1, 2012, Pages 55-62

  Fong, Kimberlee S ^a   Tomford, J Walton ^a   Teixeira, Lucileia ^a   Fraser, Thomas G ^a   Van Duin, David ^a   Yen Lieberman, Belinda ^a   Gordon, Steve M ^a   Miranda, Cyndee ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EPIDEMIC; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INTERFERON GAMMA RELEASE ASSAY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 84861310213     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0992     Document Type: Article

References (25)

1. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174(3):349-355. (Pubitemid 44156616)
2. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007;11(6):593-605. (Pubitemid 46868618)
3. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A;Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005;54(RR-15):49-55.
4. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K;IGRA Expert Committee;Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1-25.
5. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med. 2007;13(5):175-182. (Pubitemid 46687128)
6. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med. 2007;4(6):e208.
7. Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J. Reproducibility of QuantiFERON-TB Gold In-Tube assay. Clin Vaccine Immunol. 2008;15(3):425-432. (Pubitemid 351967072)
8. Davidow AL. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis. Int J Tuberc Lung Dis. 2009;13(11):1411-1415.
9. Fraser TG, Kowalczyk J, Schmitt S, et al. Active tuberculosis in a healthcare worker: are you ready? Infect Control Hosp Epidemiol. 2009;30(1):80-82.
10. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med. 1995;332(2):92-98.
11. QuantiFERON-TB-Gold In-Tube. Quantiferon technology. Cellestis website http://www.cellestis.com/IRM/Content/pdf/QuantiFeron%20US%20VerK-JULY2011-ttf. pdf. Accessed March 15, 2011.
12. Harada N, Higuchi K, Yoshiyama T, et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect. 2008;56(5):348-353.
13. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-γassay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE. 2009;4(12):e8517.
14. Pai M, Joshi R, Dogra S, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis. 2009;13(1):84-92.
15. Zwerling A, van den Hof S, Scholten J, et al. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax. 2012;67(1):62-70.
16. Gandra S, Scott WS, Somaraju V, Wang H, Wilton S, Feigenbaum M. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol. 2010;31(12):1279-1285.
17. Schablon A, Harling M, Diel R, Ringshausen FC, Torres Costa J, Nienhaus A. Serial testing with an interferon-γrelease assay in German healthcare workers. GMS Krankenhhyg Interdiszip. 2010;5(2):1-8.
18. Yoshiyama T, Harada N, Higuchi K, Nakajima Y, Ogata H. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays. Epidemiol Infect. 2009;137(12):1691-1698.
19. Veerapathran A, Joshi R, Goswami K, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One; 2008;3(3):e1850
20. Detjen AK, Loebenberg L, Grewal HM, et al. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol. 2009;16(8):1170-1175.
21. Public Health Agency of Canada. Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection-2010 update. Can Commun Dis Rep. 2010;36(ACS-5):1-22.
22. Hill PC, Brookes RH, Fox A, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 2007;4(6):e192.
23. van Zyl-Smit RN, Pai M, Peprah K, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009;180(1):49-58.
24. Torres Costa J, Silva R, SáR, Cardoso MJ, Nienhaus A. Serial testing with the interferon-γrelease assay in Portuguese healthcare workers. Int Arch Occup Environ Health. 2011;84(4):461-469.
25. Ringshausen FC, Nienhaus A, Torres Costa J, et al. Within-subject variability of Mycobacterium tuberculosis -specific gamma interferon responses in German health care workers. Clin Vaccine Immunol. 2011;18(7):1176-1182.